403 related articles for article (PubMed ID: 33466691)
1. Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer.
Pallerla S; Abdul AURM; Comeau J; Jois S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466691
[TBL] [Abstract][Full Text] [Related]
2. HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development.
Arab A; Yazdian-Robati R; Behravan J
Arch Immunol Ther Exp (Warsz); 2020 Jan; 68(1):2. PubMed ID: 31915932
[TBL] [Abstract][Full Text] [Related]
3. HER2-Based Immunotherapy for Breast Cancer.
Cui N; Shi J; Yang C
Cancer Biother Radiopharm; 2018 Jun; 33(5):169-175. PubMed ID: 29874101
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Vaccines: Disappointing or Promising?
Zhu SY; Yu KD
Front Immunol; 2022; 13():828386. PubMed ID: 35154149
[TBL] [Abstract][Full Text] [Related]
5. Developing anti-HER2 vaccines: Breast cancer experience.
Al-Awadhi A; Lee Murray J; Ibrahim NK
Int J Cancer; 2018 Nov; 143(9):2126-2132. PubMed ID: 29693245
[TBL] [Abstract][Full Text] [Related]
6. Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines.
Wiedermann U; Davis AB; Zielinski CC
Breast Cancer Res Treat; 2013 Feb; 138(1):1-12. PubMed ID: 23340862
[TBL] [Abstract][Full Text] [Related]
7. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
[TBL] [Abstract][Full Text] [Related]
8. Progress in Vaccine Therapies for Breast Cancer.
Li X; Bu X
Adv Exp Med Biol; 2017; 1026():315-330. PubMed ID: 29282691
[TBL] [Abstract][Full Text] [Related]
9. Vaccine immunotherapy in breast cancer treatment: promising, but still early.
Curigliano G; Spitaleri G; Dettori M; Locatelli M; Scarano E; Goldhirsch A
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1225-41. PubMed ID: 17892423
[TBL] [Abstract][Full Text] [Related]
10. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
[TBL] [Abstract][Full Text] [Related]
11. Emerging Therapeutic Options for HER2-Positive Breast Cancer.
Martin M; López-Tarruella S
Am Soc Clin Oncol Educ Book; 2016; 35():e64-70. PubMed ID: 27249772
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic breast cancer vaccines: a new strategy for early-stage disease.
Shumway NM; Ibrahim N; Ponniah S; Peoples GE; Murray JL
BioDrugs; 2009; 23(5):277-87. PubMed ID: 19754218
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer.
Crosby EJ; Acharya CR; Haddad AF; Rabiola CA; Lei G; Wei JP; Yang XY; Wang T; Liu CX; Wagner KU; Muller WJ; Chodosh LA; Broadwater G; Hyslop T; Shepherd JH; Hollern DP; He X; Perou CM; Chai S; Ashby BK; Vincent BG; Snyder JC; Force J; Morse MA; Lyerly HK; Hartman ZC
Clin Cancer Res; 2020 Sep; 26(17):4670-4681. PubMed ID: 32732224
[TBL] [Abstract][Full Text] [Related]
14. The clinical development of vaccines for HER2
Costa RLB; Soliman H; Czerniecki BJ
Cancer Treat Rev; 2017 Dec; 61():107-115. PubMed ID: 29125981
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy as a partner for HER2-directed therapies.
Clifton GT; Peoples AGE
Expert Rev Anticancer Ther; 2021 Jul; 21(7):739-746. PubMed ID: 33666116
[No Abstract] [Full Text] [Related]
16. Immunotherapy in breast cancer: Current status and future directions.
Basu A; Ramamoorthi G; Jia Y; Faughn J; Wiener D; Awshah S; Kodumudi K; Czerniecki BJ
Adv Cancer Res; 2019; 143():295-349. PubMed ID: 31202361
[TBL] [Abstract][Full Text] [Related]
17. AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence.
McCarthy PM; Clifton GT; Vreeland TJ; Adams AM; O'Shea AE; Peoples GE
Expert Opin Investig Drugs; 2021 Jan; 30(1):5-11. PubMed ID: 33191799
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer vaccines; A comprehensive and updated review.
Al-Hawary SIS; Saleh EAM; Mamajanov NA; S Gilmanova N; Alsaab HO; Alghamdi A; Ansari SA; Alawady AHR; Alsaalamy AH; Ibrahim AJ
Pathol Res Pract; 2023 Sep; 249():154735. PubMed ID: 37611432
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice.
Cao J; Jin Y; Li W; Zhang B; He Y; Liu H; Xia N; Wei H; Yan J
BMC Immunol; 2013 Aug; 14():39. PubMed ID: 23941509
[TBL] [Abstract][Full Text] [Related]
20. Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo.
Morse MA; Wei J; Hartman Z; Xia W; Ren XR; Lei G; Barry WT; Osada T; Hobeika AC; Peplinski S; Jiang H; Devi GR; Chen W; Spector N; Amalfitano A; Lyerly HK; Clay TM
Int J Cancer; 2010 Jun; 126(12):2893-903. PubMed ID: 19856307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]